UAE Docetaxel Market Size & Outlook, 2025-2030

The docetaxel market in the UAE is expected to reach a projected revenue of US$ 3.8 million by 2030. A compound annual growth rate of 7.2% is expected of the UAE docetaxel market from 2025 to 2030.
Revenue, 2024 (US$M)
$2.5
Forecast, 2030 (US$M)
$3.8
CAGR, 2025 - 2030
7.2%
Report Coverage
UAE

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UAE docetaxel market, 2018-2030 (US$M)

UAE docetaxel market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UAE docetaxel market highlights

  • The UAE docetaxel market generated a revenue of USD 2.5 million in 2024 and is expected to reach USD 3.8 million by 2030.
  • The UAE market is expected to grow at a CAGR of 7.2% from 2025 to 2030.
  • In terms of segment, breast cancer was the largest revenue generating indication in 2024.
  • Squamous Cell Carcinoma of the Head and Neck is the most lucrative indication segment registering the fastest growth during the forecast period.


Docetaxel market data book summary

Market revenue in 2024USD 2.5 million
Market revenue in 2030USD 3.8 million
Growth rate7.2% (CAGR from 2025 to 2030)
Largest segmentBreast cancer
Fastest growing segmentSquamous Cell Carcinoma of the Head and Neck
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBreast Cancer, Non-Small Cell Lung Cancer (NSCLC), Hormone Refractory Prostate Cancer, Gastric Adenocarcinoma, Squamous Cell Carcinoma of the Head and Neck
Key market players worldwidePhyton Biotech, Rochem, Alchem International, LGM Pharma, HRV Global LifeSciences, Teva Active Pharmaceutical Ingredients, Arch Pharmalabs, Aspen Pharmacare, Cipla Ltd DR


Other key industry trends

  • In terms of revenue, UAE accounted for 0.2% of the global docetaxel market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa docetaxel market is projected to lead the regional market in terms of revenue in 2030.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 3.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Docetaxel Market Companies

Name Profile # Employees HQ Website
Teva Active Pharmaceutical Ingredients View profile 5001-10000 http://www.tapi.com/
HRV Global LifeSciences View profile 101-250 Hyderabad, Andhra Pradesh, India, Asia https://hrvglobal.com
Alchem International View profile 11-50 Delhi, Delhi, India, Asia https://www.alchemlife.com
Rochem View profile 11-50 Hauppauge, New York, United States, North America https://rochemintl.com/
Phyton Biotech View profile 51-100 Delta, British Columbia, Canada, North America http://www.phytonbiotech.com
Arch Pharmalabs View profile 5001-10000 Mumbai, Maharashtra, India, Asia http://www.archpharmalabs.com
Aspen Pharmacare View profile 10001+ Durban, NA - South Africa, South Africa, Africa https://www.aspenpharma.com
LGM Pharma View profile 101-250 Nashville, Tennessee, United States, North America https://lgmpharma.com/
Cipla Ltd DR View profile 38955 Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 https://www.cipla.com

UAE docetaxel market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to docetaxel market will help companies and investors design strategic landscapes.


Breast cancer was the largest segment with a revenue share of 36% in 2024. Horizon Databook has segmented the UAE docetaxel market based on breast cancer, non-small cell lung cancer (nsclc), hormone refractory prostate cancer, gastric adenocarcinoma, squamous cell carcinoma of the head and neck covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to UAE docetaxel market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UAE docetaxel market databook

  • Our clientele includes a mix of docetaxel market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UAE docetaxel market , including forecasts for subscribers. This country databook contains high-level insights into UAE docetaxel market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UAE Indication - Docetaxel Market size, 2024 - 2030 (US$M)

UAE Docetaxel Market Outlook Share, 2024 & 2030 (US$M)

UAE Indication - Docetaxel Market size, 2024 - 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online